DK1023059T3 - Farmaceutiske præparater - Google Patents

Farmaceutiske præparater

Info

Publication number
DK1023059T3
DK1023059T3 DK98961013T DK98961013T DK1023059T3 DK 1023059 T3 DK1023059 T3 DK 1023059T3 DK 98961013 T DK98961013 T DK 98961013T DK 98961013 T DK98961013 T DK 98961013T DK 1023059 T3 DK1023059 T3 DK 1023059T3
Authority
DK
Denmark
Prior art keywords
pentaerythritol
pharmaceuticals
dinatrate
pentaerythrito
petn
Prior art date
Application number
DK98961013T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Guenther
Sabine Freitag
Ulrike Kuntze
Wilhelm Thomas Lehr
Original Assignee
Alpharma Isis Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma Isis Gmbh & Co Kg filed Critical Alpharma Isis Gmbh & Co Kg
Application granted granted Critical
Publication of DK1023059T3 publication Critical patent/DK1023059T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98961013T 1997-10-16 1998-10-16 Farmaceutiske præparater DK1023059T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19745618 1997-10-16

Publications (1)

Publication Number Publication Date
DK1023059T3 true DK1023059T3 (da) 2006-04-24

Family

ID=7845649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98961013T DK1023059T3 (da) 1997-10-16 1998-10-16 Farmaceutiske præparater

Country Status (12)

Country Link
EP (1) EP1023059B1 (fr)
AT (1) ATE313323T1 (fr)
AU (1) AU1660399A (fr)
CZ (1) CZ301265B6 (fr)
DE (3) DE29880094U1 (fr)
DK (1) DK1023059T3 (fr)
ES (1) ES2255193T3 (fr)
HU (1) HUP0100634A3 (fr)
PL (1) PL340386A1 (fr)
SK (1) SK284769B6 (fr)
WO (1) WO1999018930A2 (fr)
ZA (1) ZA989356B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087926A2 (fr) * 1998-06-24 2001-04-04 Alpharma-Isis GmbH & Co. KG Substrats analytiques et agents antioxydants
DE102008050597A1 (de) 2008-10-09 2010-04-15 Actavis Deutschland Gmbh & Co. Kg Pharmazeutische Zubereitungen zur Anwendung in einem Verfahren zur therapeutischen Behandlung von Hörsturz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
ATE49503T1 (de) * 1982-09-29 1990-02-15 Ici America Inc Organische nitrate enthaltende arzneimischungen, die gegen detonation durch feuer stabil sind.
DE3328094A1 (de) * 1983-08-04 1985-02-21 H. Trommsdorff GmbH & Co, 5110 Alsdorf Phlegmatisierte pharmazeutische zubereitung von explosionsfaehigen salpetersaeureestern
DE68906539D1 (de) * 1989-02-20 1993-06-17 Soorianarain Baligadoo Pharmazeutische herzschuetzende zusammensetzungen enthaltend amiodaron, ein nitroderivat, naemlich isosorbiddinitrat, und gegebenenfalls einen betablocker.
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen

Also Published As

Publication number Publication date
EP1023059B1 (fr) 2005-12-21
HUP0100634A3 (en) 2003-07-28
CZ20001342A3 (cs) 2000-09-13
AU1660399A (en) 1999-05-03
EP1023059A2 (fr) 2000-08-02
WO1999018930A2 (fr) 1999-04-22
ES2255193T3 (es) 2006-06-16
WO1999018930A3 (fr) 1999-10-07
DE59813300D1 (de) 2006-01-26
ATE313323T1 (de) 2006-01-15
PL340386A1 (en) 2001-01-29
ZA989356B (en) 1998-11-16
HUP0100634A2 (hu) 2001-07-30
CZ301265B6 (cs) 2009-12-23
SK284769B6 (sk) 2005-11-03
DE29880094U1 (de) 2000-05-18
DE19847781A1 (de) 1999-04-22
SK5382000A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
TR199802423T2 (xx) Konsantre antikor terkibi.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
DK65293A (da) Fremgangsmåde til administrering af taxol
DE69921138D1 (de) Arzneimittel freisetzendes system enthaltend ein homeobox-peptid und ein zytotoxisches oder antineoplastisches mittel
TR199800631A2 (xx) Ecza form�lasyonu.
CA2170255A1 (fr) Composition pharmaceutique pour therapie par immunopotentialisation
TW261615B (fr)
HUP0001136A2 (hu) Limfatikus tumorok kezelésére szolgáló gyógyszerkészítmények
YU52999A (sh) Kombinacija analgetika
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
HUP0200055A2 (hu) 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények
DK1023059T3 (da) Farmaceutiske præparater
AR019331A2 (es) Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
WO1998038994A3 (fr) Preparation combinee d'acide 2-methylthiazolidine-2,4-dicarboxylique et de paracetamol
BR9714945A (pt) Composição topicamente aplicável para introdução de fármacos peptidaceosos em organismos vivos
MY104088A (en) Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives.
TH27071A (th) อนุพันธ์5-แนฟธาเลน-1-อิล-1, 3-ไดออกเซน, การเตรียมสารเหล่านั้นและการใช้สารเหล่านั้นในการรักษาโรค